Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD.
Fernández-Sáez EM, Losarcos M, Becerril S, Valentí V, Moncada R, Martín M, Burrell MA, Catalán V, Gómez-Ambrosi J, Mugueta C, Colina I, Silva C, Escalada J, Frühbeck G, Rodríguez A.
Fernández-Sáez EM, et al. Among authors: valenti v.
Metabolism. 2023 Oct;147:155663. doi: 10.1016/j.metabol.2023.155663. Epub 2023 Jul 29.
Metabolism. 2023.
PMID: 37517791
Free article.